Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 100

1.

Similar MPA exposure on modified release and regular tacrolimus.

Filler G, Vinks AA, Huang SH, Jevnikar A, Muirhead N.

Ther Drug Monit. 2014 Jun;36(3):353-7. doi: 10.1097/FTD.0000000000000021.

PMID:
24365986
[PubMed - in process]
2.

Development and validation of limited sampling strategies for tacrolimus and mycophenolate in steroid-free renal transplant regimens.

Poulin E, Greanya ED, Partovi N, Shapiro RJ, Al-Khatib M, Ensom MH.

Ther Drug Monit. 2011 Feb;33(1):50-5. doi: 10.1097/FTD.0b013e3182028b23.

PMID:
21157401
[PubMed - indexed for MEDLINE]
3.

Pharmacokinetics of mycophenolic acid and its glucuronide metabolites in stable adult liver transplant recipients with renal dysfunction on a low-dose calcineurin inhibitor regimen and mycophenolate mofetil.

Beckebaum S, Armstrong VW, Cicinnati VR, Streit F, Klein CG, Gerken G, Paul A, Oellerich M.

Ther Drug Monit. 2009 Apr;31(2):205-10. doi: 10.1097/FTD.0b013e31819743d9.

PMID:
19307937
[PubMed - indexed for MEDLINE]
4.
5.

Limited sampling models and Bayesian estimation for mycophenolic acid area under the curve prediction in stable renal transplant patients co-medicated with ciclosporin or sirolimus.

Musuamba FT, Rousseau A, Bosmans JL, Senessael JJ, Cumps J, Marquet P, Wallemacq P, Verbeeck RK.

Clin Pharmacokinet. 2009;48(11):745-58. doi: 10.2165/11318060-000000000-00000.

PMID:
19817503
[PubMed - indexed for MEDLINE]
6.

Mycophenolate, clinical pharmacokinetics, formulations, and methods for assessing drug exposure.

Tett SE, Saint-Marcoux F, Staatz CE, Brunet M, Vinks AA, Miura M, Marquet P, Kuypers DR, van Gelder T, Cattaneo D.

Transplant Rev (Orlando). 2011 Apr;25(2):47-57. doi: 10.1016/j.trre.2010.06.001. Epub 2010 Dec 28.

PMID:
21190834
[PubMed - indexed for MEDLINE]
7.

Clinical pharmacokinetics and pharmacodynamics of mycophenolate in solid organ transplant recipients.

Staatz CE, Tett SE.

Clin Pharmacokinet. 2007;46(1):13-58. Review.

PMID:
17201457
[PubMed - indexed for MEDLINE]
9.

Limited sampling strategy for the estimation of mycophenolic acid area under the curve in adult renal transplant patients treated with concomitant tacrolimus.

Pawinski T, Hale M, Korecka M, Fitzsimmons WE, Shaw LM.

Clin Chem. 2002 Sep;48(9):1497-504.

PMID:
12194926
[PubMed - indexed for MEDLINE]
Free Article
10.

Pharmacokinetics, efficacy, and safety of mycophenolate mofetil in combination with standard-dose or reduced-dose tacrolimus in liver transplant recipients.

Nashan B, Saliba F, Durand F, Barcéna R, Herrero JI, Mentha G, Neuhaus P, Bowles M, Patch D, Bernardos A, Klempnauer J, Bouw R, Ives J, Mamelok R, McKay D, Truman M, Marotta P.

Liver Transpl. 2009 Feb;15(2):136-47. doi: 10.1002/lt.21657.

PMID:
19177449
[PubMed - indexed for MEDLINE]
Free Article
11.

Mycophenolic acid pharmacokinetics in pediatric liver transplant recipients.

Aw MM, Brown NW, Itsuka T, Gonde CE, Adams JE, Heaton ND, Tredger JM, Mieli-Vergani G, Dhawan A.

Liver Transpl. 2003 Apr;9(4):383-8.

PMID:
12682891
[PubMed - indexed for MEDLINE]
Free Article
12.

Pharmacokinetics of mycophenolic acid and determination of area under the curve by abbreviated sampling strategy in Chinese liver transplant recipients.

Chen H, Peng C, Yu Z, Shen B, Deng X, Qiu W, Fei Y, Shen C, Zhou G, Yang W, Li H.

Clin Pharmacokinet. 2007;46(2):175-85. Erratum in: Clin Pharmacokinet. 2008 Feb;30(1):135.

PMID:
17253887
[PubMed - indexed for MEDLINE]
13.

Limited sampling strategy for the estimation of mycophenolic acid area under the concentration-time curve treated in Japanese living-related renal transplant recipients with concomitant extended-release tacrolimus.

Yamaguchi K, Fukuoka N, Kimura S, Watanabe M, Tani K, Tanaka H, Sofue T, Kosaka S, Inui M, Kakehi Y, Houchi H.

Biol Pharm Bull. 2013;36(6):1036-9. Epub 2013 Apr 5.

PMID:
23558676
[PubMed - indexed for MEDLINE]
Free Article
14.

Comparison of mycophenolic acid pharmacokinetic parameters in kidney transplant patients within the first 3 months post-transplant.

Pawinski T, Durlik M, Szlaska I, Urbanowicz A, Majchrnak J, Gralak B.

J Clin Pharm Ther. 2006 Feb;31(1):27-34.

PMID:
16476117
[PubMed - indexed for MEDLINE]
15.

[Use of limited sampling strategy for estimating area under concentration-versus-time curve of mycophenolate sodium in renal allograft recipients].

Yang SL, Gao X, Wang QH, Zhang J, Cai JQ, Guo JQ, Tang MY, Shang LL, Tan JM.

Zhonghua Yi Xue Za Zhi. 2013 Dec 24;93(48):3841-6. Chinese.

PMID:
24548445
[PubMed - in process]
16.

Age-dependency of mycophenolate mofetil dosing in combination with tacrolimus after pediatric renal transplantation.

Filler G, Foster J, Berard R, Mai I, Lepage N.

Transplant Proc. 2004 Jun;36(5):1327-31.

PMID:
15251324
[PubMed - indexed for MEDLINE]
17.

Mycophenolic acid exposure after administration of mycophenolate mofetil in the presence and absence of cyclosporin in renal transplant recipients.

Kuypers DR, Ekberg H, Grinyó J, Nashan B, Vincenti F, Snell P, Mamelok RD, Bouw RM.

Clin Pharmacokinet. 2009;48(5):329-41. doi: 10.2165/00003088-200948050-00005.

PMID:
19566116
[PubMed - indexed for MEDLINE]
18.

Limited sampling strategy for simultaneous estimation of the area under the concentration-time curve of tacrolimus and mycophenolic acid in adult renal transplant recipients.

Miura M, Satoh S, Niioka T, Kagaya H, Saito M, Hayakari M, Habuchi T, Suzuki T.

Ther Drug Monit. 2008 Feb;30(1):52-9. doi: 10.1097/FTD.0b013e31815f5416.

PMID:
18223463
[PubMed - indexed for MEDLINE]
19.

Effect of cyclosporine on steady-state pharmacokinetics of MPA in renal transplant recipients is not affected by the MPA formulation: analysis based on therapeutic drug monitoring data.

Trkulja V, Lalić Z, Nađ-Škegro S, Lebo A, Granić P, Lovrić M, Pasini J, Božina N.

Ther Drug Monit. 2014 Aug;36(4):456-64. doi: 10.1097/FTD.0000000000000052.

PMID:
24518562
[PubMed - in process]
20.

Long-term changes in mycophenolic acid exposure in combination with tacrolimus and corticosteroids are dose dependent and not reflected by trough plasma concentration: a prospective study in 100 de novo renal allograft recipients.

Kuypers DR, Claes K, Evenepoel P, Maes B, Coosemans W, Pirenne J, Vanrenterghem Y.

J Clin Pharmacol. 2003 Aug;43(8):866-80.

PMID:
12953344
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk